Occlusal equilibration versus sham therapies for long-term relief of temporomandibular disorder pain — post‑trial follow‑up
Official title: OEST Protocol: Physiologically Oriented Occlusal Equilibration Versus Sham Therapy for Chronic Temporomandibular Disorders (TMDs): 10 Years Post-trial Follow-up
Run by University of Santiago de Compostela · NCT07445516 · Data updated 2026-11-12
This follow-up tests whether a bite‑adjustment procedure called physiologically oriented occlusal equilibration provides lasting pain relief for adults who previously had chronic TMD and were treated at the University of Santiago de Compostela.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | University of Santiago de Compostela Academic / other |
| Locations | 2 sites (Santiago de Compostela, A Coruña and 1 other locations) |
| Status | Recruiting |
| Started | February 16, 2026 |
| Main results expected | June 30, 2026 |
| Study ends | August 30, 2026 |
| Registry record updated | March 4, 2026 |
| Trial ID | NCT07445516 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–85 with DC/TMD‑diagnosed muscle or joint pain who previously received occlusal equilibration at the University of Santiago de Compostela, are fully dentate or have adequately restored occlusion, and had moderate pretreatment pain (VAS/NRS 4–9).
✕Probably not a fit
Patients with major psychiatric disorders, opioid addiction, recent orthodontic treatment, severe tooth mobility, other indistinguishable dominant pain conditions, ongoing litigation, or those who were not treated at the USC occlusion unit are unlikely to gain from this specific follow‑up evaluation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational long‑term follow‑up contacts patients who previously underwent physiologically oriented occlusal equilibration (POOE) or sham therapies at the University of Santiago de Compostela to document pain outcomes over several years. Eligible participants were adults diagnosed with muscle and/or joint TMD according to DC/TMD, fully dentate or adequately restored, with moderate pretreatment pain and prior conservative care. The protocol collects long‑term pain intensity measures (original baseline, 6‑month results, and multiple‑year follow‑up) to determine whether initial benefits persist. Standard exclusion criteria (major psychiatric disease, opioid addiction, recent orthodontics, severe tooth mobility, indistinguishable other pain conditions, active litigation) limit confounding and select for typical chronic TMD patients treated at this center.
Why it matters
Potential benefit: If positive, the follow‑up could show that occlusal equilibration produces durable, years‑long reductions in TMD pain for some patients.
How similar studies have gone: Previous randomized work showed POOE was more effective than placebo at 6 months, but long‑term effectiveness beyond 3–5 years remains uncertain and is the main gap this follow‑up addresses.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Previous occlusal equilibration for TMD pain at the University of Santiago. * Be diagnosed with joint and/or muscle TMD pain according to DC/TMD. * Be aged 18-85 years. * Be completely dentate with normal or adequately restored occlusion (fixed crowns/bridges allowed). * Report pretreatment significant TMD pain (VAS/NRS 4-9 on a 0-10 scale). * Have actively sought treatment and been referred to the University/Hospital service. * Have undergone ≥6 months of prior conservative therapy. Exclusion Criteria: * Psychosis, major depression, substance abuse, or cognitive impairment. * Opioid (morphine-derivative) addiction. * Ongoing litigation or disability claims related to chronic pain. * Dental professional background. * Orthodontic treatment within the last 2 years. * Severe tooth mobility (grade 3). * Other pain conditions indistinguishable from or more severe than TMD pain. * Additionally, patients will be excluded if minimally invasive occlusal adjustment cannot achieve equilibration, defined by: 2 mm discrepancy between maximal intercuspation and centric occlusion, and/or 4 mm total interarch discrepancy (≥2 mm on one side) in defined premolar/molars reference points, measured intraorally using a Boley gauge.
Where it's running
-
Universidad de Santiago de Compostela
Santiago de Compostela, A Coruña, Spain Recruiting -
Urbano Santana Penín
Santiago de Compostela, A Coruña, Spain Enrolling by invitation
Study contacts
- Principal investigator: José López-Cedrún, Dr. — Complejo Hospitalario Universitario de A Coruña
- Study coordinator: URBANO SANTANA PENIN, Prof.
- Email: urbano.santana@usc.es
- Phone: + 34 647 344 093
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted approach to diagnose and treat temporomandibular disorders
This study tests a machine-learning approach that uses clinical data, CBCT, and MRI to guide personalized treatment for people with temporomandibular disorders.
-
Occlusal splint plus Rocabado jaw exercises for temporomandibular disorder
This project will see if adding daily Rocabado jaw exercises to nightly occlusal splint use helps adults (18-65) with temporomandibular disorder reduce pain, improve jaw movement, and change muscle mechanical properties.
-
See if the Modjaw digital jaw impressions help diagnose TMJ disc displacement
This interventional study tests whether Modjaw digital jaw recordings can help diagnose TMJ disc displacement in adults who already need an MRI for confirmation.
-
Online or group physiotherapy versus one-on-one physiotherapy for jaw (TMD) muscle pain
This trial will test whether online or group physiotherapy works as well as individual physiotherapy for adults with TMD-related jaw muscle pain.
-
Virtual planning for total temporomandibular joint replacement
This project sees if virtual planning using standard (non‑custom) TMJ prostheses can plan jaw and implant positioning for patients who already had total TMJ replacement.
-
Liquid-phase concentrated growth factor versus arthrocentesis for temporomandibular disc displacement
This trial will test whether injecting liquid-phase concentrated growth factor into the temporomandibular joint works better than standard arthrocentesis for adults (18–45) with unilateral disc displacement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.